229 related articles for article (PubMed ID: 15026116)
1. Heparin-binding epidermal growth factor-like growth factor: a component in chromaffin granules which promotes the survival of nigrostriatal dopaminergic neurones in vitro and in vivo.
Hanke M; Farkas LM; Jakob M; Ries R; Pohl J; Sullivan AM
Neuroscience; 2004; 124(4):757-66. PubMed ID: 15026116
[TBL] [Abstract][Full Text] [Related]
2. Protein from chromaffin granules promotes survival of mesencephalic dopaminergic neurons by an EGF-receptor ligand-mediated mechanism.
Krieglstein K; Unsicker K
J Neurosci Res; 1997 Apr; 48(1):18-30. PubMed ID: 9086178
[TBL] [Abstract][Full Text] [Related]
3. Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons.
Iwakura Y; Piao YS; Mizuno M; Takei N; Kakita A; Takahashi H; Nawa H
J Neurochem; 2005 May; 93(4):974-83. PubMed ID: 15857400
[TBL] [Abstract][Full Text] [Related]
4. Qualitative and quantitative re-evaluation of epidermal growth factor-ErbB1 action on developing midbrain dopaminergic neurons in vivo and in vitro: target-derived neurotrophic signaling (Part 1).
Iwakura Y; Zheng Y; Sibilia M; Abe Y; Piao YS; Yokomaku D; Wang R; Ishizuka Y; Takei N; Nawa H
J Neurochem; 2011 Jul; 118(1):45-56. PubMed ID: 21517852
[TBL] [Abstract][Full Text] [Related]
5. Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo.
Moses D; Drago J; Teper Y; Gantois I; Finkelstein DI; Horne MK
Neuroscience; 2008 Jun; 154(2):606-20. PubMed ID: 18472226
[TBL] [Abstract][Full Text] [Related]
6. Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons.
Piltonen M; Bespalov MM; Ervasti D; Matilainen T; Sidorova YA; Rauvala H; Saarma M; Männistö PT
Exp Neurol; 2009 Oct; 219(2):499-506. PubMed ID: 19615368
[TBL] [Abstract][Full Text] [Related]
7. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) regulates survival of midbrain dopaminergic neurons.
Farkas LM; Krieglstein K
J Neural Transm (Vienna); 2002 Mar; 109(3):267-77. PubMed ID: 11956950
[TBL] [Abstract][Full Text] [Related]
8. Trophic and protective effects of growth/differentiation factor 5, a member of the transforming growth factor-beta superfamily, on midbrain dopaminergic neurons.
Krieglstein K; Suter-Crazzolara C; Hötten G; Pohl J; Unsicker K
J Neurosci Res; 1995 Dec; 42(5):724-32. PubMed ID: 8600306
[TBL] [Abstract][Full Text] [Related]
9. Dopamine-dependent ectodomain shedding and release of epidermal growth factor in developing striatum: target-derived neurotrophic signaling (Part 2).
Iwakura Y; Wang R; Abe Y; Piao YS; Shishido Y; Higashiyama S; Takei N; Nawa H
J Neurochem; 2011 Jul; 118(1):57-68. PubMed ID: 21534959
[TBL] [Abstract][Full Text] [Related]
10. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo.
Lindholm P; Voutilainen MH; Laurén J; Peränen J; Leppänen VM; Andressoo JO; Lindahl M; Janhunen S; Kalkkinen N; Timmusk T; Tuominen RK; Saarma M
Nature; 2007 Jul; 448(7149):73-7. PubMed ID: 17611540
[TBL] [Abstract][Full Text] [Related]
11. Effects of growth/differentiation factor 5 on the survival and morphology of embryonic rat midbrain dopaminergic neurones in vitro.
O'Keeffe GW; Dockery P; Sullivan AM
J Neurocytol; 2004 Sep; 33(5):479-88. PubMed ID: 15906156
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
[TBL] [Abstract][Full Text] [Related]
13. Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease.
Gouhier C; Chalon S; Aubert-Pouessel A; Venier-Julienne MC; Jollivet C; Benoit JP; Guilloteau D
Synapse; 2002 Jun; 44(3):124-31. PubMed ID: 11954043
[TBL] [Abstract][Full Text] [Related]
14. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Agrawal AK
Neurosci Lett; 2006 May; 398(1-2):44-9. PubMed ID: 16423459
[TBL] [Abstract][Full Text] [Related]
15. Intraventricular infusion of epidermal growth factor restores dopaminergic pathway in hemiparkinsonian rats.
Pezzoli G; Zecchinelli A; Ricciardi S; Burke RE; Fahn S; Scarlato G; Carenzi A
Mov Disord; 1991; 6(4):281-7. PubMed ID: 1684638
[TBL] [Abstract][Full Text] [Related]
16. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
Lorenc-Koci E; Antkiewicz-Michaluk L; Kamińska A; Lenda T; Zieba B; Wierońska J; Smiałowska M; Schulze G; Rommelspacher H
Neuroscience; 2008 Oct; 156(4):973-86. PubMed ID: 18809471
[TBL] [Abstract][Full Text] [Related]
17. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F
Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
[TBL] [Abstract][Full Text] [Related]
18. Heparin-binding epidermal growth factor-like growth factor stimulates cell proliferation in cerebral cortical cultures through phosphatidylinositol 3'-kinase and mitogen-activated protein kinase.
Jin K; Mao XO; Del Rio Guerra G; Jin L; Greenberg DA
J Neurosci Res; 2005 Aug; 81(4):497-505. PubMed ID: 15952178
[TBL] [Abstract][Full Text] [Related]
19. A sequential intrastriatal dopaminergic graft strategy in the rodent model for Parkinson's disease: implications for graft survival and targeting.
Baker KA; Purdy MB; Sadi D; Mukhida K; Mendez I
Cell Transplant; 2002; 11(3):185-93. PubMed ID: 12075984
[TBL] [Abstract][Full Text] [Related]
20. The physiological and pharmacological role of basic fibroblast growth factor in the dopaminergic nigrostriatal system.
Grothe C; Timmer M
Brain Res Rev; 2007 Apr; 54(1):80-91. PubMed ID: 17229467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
